Postdoctoral Research Fellow , Cancer Biomarkers Team (ID 568)

For general information on Post Doc's at The ICR can be found here.

Key Requirements

The successful candidate must have experience in molecular & cellular biology techniques and experience in developing sequencing assays.  Familiarity with contemporary approaches to target validation and drug discovery are desirable.

The ICR has a workforce agreement stating that Postdoctoral Training Fellows can only be employed for up  to 7 years as PDTF at the ICR, providing total postdoctoral experience (including previous employment at this level elsewhere) does not exceed 10 years

Department/Directorate Information:

Within the Institute of Cancer Research, the Divisions of Clinical Studies and Cancer Therapeutics play a key role in developing new drugs for treating cancer.  It comprises both clinical and laboratory staff, covering a range of interests and tumour types.  All the clinical and laboratory facilities are based in the Sutton branch of The Institute and Royal Marsden Hospital, and there is a special responsibility for the Drug Development Unit. 

Professor Johann de Bono’s team conducts biomarker-driven clinical and translational research to accelerate the development of novel cancer therapies and improve understanding of cancer biology, drug sensitivity and resistance. His team focuses on improving prostate cancer care that have led pivotal phase III trials of several prostate cancer drugs including abiraterone, cabazitaxel, enzalutamide and olaparib as well more recently ipatasertib and lutetium-PSMA. His team consists of basic and clinical scientists, which is embedded in a vibrant world-class research environment.

We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Professor Johann de Bono on [email protected]